Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of midazolam, erythromycin, and dexamethasone

被引：0
|
作者：
Corinna Lanzarotti
Giorgia Rossi
机构：
[1] Helsinn Healthcare SA,Corporate Clinical Development, Statistics and Data Management
[2] Helsinn Healthcare SA,Corporate Clinical Development
来源：
Supportive Care in Cancer | 2013年 / 21卷
关键词：
Netupitant; Drug–drug interaction; Midazolam; Erythromycin; Dexamethasone; CYP3A4 substrates;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2783 / 2791
页数：8
相关论文
共 20 条
  • [1] Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of midazolam, erythromycin, and dexamethasone
    Lanzarotti, Corinna
    Rossi, Giorgia
    SUPPORTIVE CARE IN CANCER, 2013, 21 (10) : 2783 - 2791
  • [2] Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of palonosetron and impact of the fixed dose combination of netupitant and palonosetron when coadministered with ketoconazole, rifampicin, and oral contraceptives
    Calcagnile, Selma
    Lanzarotti, Corinna
    Rossi, Giorgia
    Henriksson, Anders
    Kammerer, Klaus Peter
    Timmer, Wolfgang
    SUPPORTIVE CARE IN CANCER, 2013, 21 (10) : 2879 - 2887
  • [3] Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of palonosetron and impact of the fixed dose combination of netupitant and palonosetron when coadministered with ketoconazole, rifampicin, and oral contraceptives
    Selma Calcagnile
    Corinna Lanzarotti
    Giorgia Rossi
    Anders Henriksson
    Klaus Peter Kammerer
    Wolfgang Timmer
    Supportive Care in Cancer, 2013, 21 : 2879 - 2887
  • [4] In vitro and in vivo pharmacological characterization of the novel NK1 receptor selective antagonist Netupitant
    Rizzi, Anna
    Campi, Barbara
    Camarda, Valeria
    Molinari, Stefano
    Cantoreggi, Sergio
    Regoli, Domenico
    Pietra, Claudio
    Calo, Girolamo
    PEPTIDES, 2012, 37 (01) : 86 - 97
  • [5] Simulation of the oxidative metabolization pattern of netupitant, an NK1 receptor antagonist, by electrochemistry coupled to mass spectrometry
    Chira, Ruxandra
    Fangmeyer, Jens
    Neaga, Ioan O.
    Zaharia, Valentin
    Karst, Uwe
    Bodoki, Ede
    Oprean, Radu
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2021, 11 (05) : 661 - 666
  • [6] Efficacy benefit of an NK1 receptor antagonist (NK1RA) in patients receiving carboplatin: supportive evidence with NEPA (a fixed combination of the NK1 RA, netupitant, and palonosetron) and aprepitant regimens
    Jordan, Karin
    Gralla, Richard
    Rizzi, Giada
    Kashef, Kimia
    SUPPORTIVE CARE IN CANCER, 2016, 24 (11) : 4617 - 4625
  • [7] Efficacy benefit of an NK1 receptor antagonist (NK1RA) in patients receiving carboplatin: supportive evidence with NEPA (a fixed combination of the NK1 RA, netupitant, and palonosetron) and aprepitant regimens
    Karin Jordan
    Richard Gralla
    Giada Rizzi
    Kimia Kashef
    Supportive Care in Cancer, 2016, 24 : 4617 - 4625
  • [8] Netupitant and palonosetron trigger NK1 receptor internalization in NG108-15 cells
    Ajit G. Thomas
    Marigo Stathis
    Camilo Rojas
    Barbara S. Slusher
    Experimental Brain Research, 2014, 232 : 2637 - 2644
  • [9] Netupitant and palonosetron trigger NK1 receptor internalization in NG108-15 cells
    Thomas, Ajit G.
    Stathis, Marigo
    Rojas, Camilo
    Slusher, Barbara S.
    EXPERIMENTAL BRAIN RESEARCH, 2014, 232 (08) : 2637 - 2644
  • [10] Impact of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of ondansetron and dexamethasone
    Johnson, Brendan
    Adams, Laurel
    Lu, Emily
    Zhang, Ke
    Lebowitz, Peter
    Lates, Christian
    Blum, Robert
    SUPPORTIVE CARE IN CANCER, 2009, 17 (09) : 1177 - 1185
12